دورية أكاديمية
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
| العنوان: | Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations |
|---|---|
| المؤلفون: | Jiang, Yi-ZhouAff1, Aff2, Aff3, Aff4, Aff5, Ge, Li-PingAff1, Aff2, Aff3, Aff4, Jin, XiAff1, Aff2, Aff3, Aff4, Fan, LeiAff1, Aff2, Aff3, Aff4, He, MinAff1, Aff2, Aff3, Aff4, Liu, YinAff1, Aff2, Aff3, Aff4, Chen, LiAff1, Aff2, Aff3, Aff4, Zuo, Wen-JiaAff1, Aff2, Aff3, Aff4, Wu, JiongAff1, Aff2, Aff3, Aff4, Aff5, Liu, Guang-YuAff1, Aff2, Aff3, Aff4, Aff5, Di, Gen-HongAff1, Aff2, Aff3, Aff4, Aff5, Wang, Zhong-HuaAff1, Aff2, Aff3, Aff4, Aff5, Yu, Ke-DaAff1, Aff2, Aff3, Aff4, Aff5, Shao, Zhi-MingAff1, Aff2, Aff3, Aff4, Aff5 |
| المصدر: | Breast Cancer Research and Treatment. 185(2):371-380 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 01676806 15737217 |
|---|---|
| DOI: | 10.1007/s10549-020-05940-8 |